1. Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
- Author
-
Suárez-García, Inés, Alejos, Belén, Hernando Sebastian, Victoria, Viñuela, Laura, Vera García, Mar, Rial-Crestelo, David, Pérez Elías, María Jesús, Albendín Iglesias, Helena, Peraire, Joaquim, Tiraboschi, Juan, Diaz Franco, Asuncion, Moreno, Santiago, Jarrin-Vera, Inmaculada, Spanish HIV/AIDS Research Network (CoRIS), Instituto de Salud Carlos III, Red de Investigación Cooperativa en Investigación en Sida (España), Plan Nacional de I+D+i (España), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), and ViiV Healthcare
- Subjects
Anti-HIV Agents ,Lamivudine ,Pyridones ,Oxazines ,HIV-1 ,Humans ,Emtricitabine ,HIV Infections ,Heterocyclic Compounds, 3-Ring - Abstract
Objectives: To assess the effectiveness and tolerability of dolutegravir (DTG)/lamivudine (3TC) among treatment-naive and virologically suppressed treatment-experienced individuals in the multicentre cohort of the Spanish HIV/AIDS Research Network (CoRIS) during the years 2018-2021. Methods: We used multivariable regression models to compare viral suppression (VS) [HIV RNA viral load (VL)
- Published
- 2023